The U.S. Centers for Disease Control and Prevention on Thursday recommended that people 60 and older get Merck & Co.'s vaccine Zostavax to protect against shingles.
The CDC said the recommendation replaces a provisional one it made in 2006 after the vaccine was approved by the Food and Drug Administration and recommended by a CDC advisory panel of immunization experts.
